Compile Data Set for Download or QSAR
Report error Found 177 Enz. Inhib. hit(s) with all data for entry = 10456
TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536562BDBM536562(US11242361, Compound 168)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536561BDBM536561(US11242361, Compound 167)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536564BDBM536564(US11242361, Compound 170)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536563BDBM536563(4-(2,6-Dimethyl-3-(2-(piperidin-1-yl)acetyl)-1H-in...)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536566BDBM536566(US11242361, Compound 172)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536565BDBM536565(US11242361, Compound 171)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536568BDBM536568(US11242361, Compound 175)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536567BDBM536567(US11242361, Compound 173)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536570BDBM536570(US11242361, Compound 177)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536569BDBM536569(US11242361, Compound 176)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536572BDBM536572(US11242361, Compound 179)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536571BDBM536571(US11242361, Compound 178)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536574BDBM536574(US11242361, Compound 181)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536573BDBM536573(4-(6-Isopropyl-2-methyl-3-(2-(piperidin-1-yl)acety...)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536576BDBM536576(N-((1-(4-Cyanophenyl)-2-methyl-3-(2-(piperidin-1-y...)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536575BDBM536575(US11242361, Compound 182)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536554BDBM536554(US11242361, Compound 156)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536553BDBM536553(US11242361, Compound 155)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536556BDBM536556(US11242361, Compound 161)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536555BDBM536555(US11242361, Compound 160)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536558BDBM536558(US11242361, Compound 163)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536557BDBM536557(4-(2-Methyl-3-(2-(piperidin-1-yl)acetyl)-1H-pyrrol...)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536560BDBM536560(US11242361, Compound 165)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536559BDBM536559(US11242361, Compound 164)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536594BDBM536594(US11242361, Compound 201)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536593BDBM536593(US11242361, Compound 200)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536596BDBM536596(US11242361, Compound 203)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536595BDBM536595(US11242361, Compound 202)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536598BDBM536598(US11242361, Compound 205)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536597BDBM536597(US11242361, Compound 204)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536600BDBM536600(US11242361, Compound 207)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536599BDBM536599(US11242361, Compound 206)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536602BDBM536602(US11242361, Compound 209)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536601BDBM536601(US11242361, Compound 208)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536604BDBM536604(US11242361, Compound 296)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536603BDBM536603(US11242361, Compound 210)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536606BDBM536606(US11242361, Compound 298)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536605BDBM536605(4-(6-Bromo-2-methyl-3-(2-(piperidin-1-yl)acetyl)-1...)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536608BDBM536608(US11242361, Compound 300)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536607BDBM536607(US11242361, Compound 299)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536578BDBM536578(US11242361, Compound 185)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536577BDBM536577(4-(2,6-Dimethyl-3-(2-(piperidin-1-yl)acetyl)-1H-py...)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536580BDBM536580(US11242361, Compound 187)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536579BDBM536579(4-(5-Amino-2-methyl-3-(2-(piperidin-1-yl)acetyl)-1...)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536582BDBM536582(US11242361, Compound 189)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536581BDBM536581(US11242361, Compound 188)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536584BDBM536584(US11242361, Compound 191)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536583BDBM536583(US11242361, Compound 190)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536588BDBM536588(US11242361, Compound 195)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 14(Human)
Proteostasis Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 536587BDBM536587(US11242361, Compound 194)
Affinity DataIC50: 550nMAssay Description:Using previously described methodology [B. H. Lee et al. Nature 2010, 467 (9), 179, the contents of which are expressly incorporated by reference her...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
US Patent

Displayed 1 to 50 (of 177 total ) | Next | Last >>
Jump to: